Interpace Biosciences: announces preliminary results for 3rd quarter 2026

What happened

• On Oct 14, 2026 Interpace Biosciences issued a press release announcing preliminary results for the 3rd quarter ended Sep 30, 2026.
• The company filed a Current Report on Form 8-K on Oct 15, 2026 and furnished the full text of the press release as Exhibit 99.1.

Key details

• Press release date: Oct 14, 2026.
• Quarter reported: 3rd quarter ended Sep 30, 2026.
• Form filed: Current Report on Form 8-K filed Oct 15, 2026.
• The filing includes forward-looking statements and notes the preliminary results may differ from final results as closing procedures are completed.

Why it may matter

• The filing reports Item 2.02 (Results of operations and financial condition), which covers the company’s announcement of preliminary financial results for the quarter ended Sep 30, 2026.
• The filing also references forward-looking statements about those preliminary results and related risks and uncertainties.
• A filing does not show why the insider traded or why the company acted.